Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease

What do we mean by validating a prognostic model?

Douglas G. Altman, Patrick Royston · Statistics in Medicine · 2000 · 1.4K citations

Pharmacy, Clinical Sciences, Method Validation +12

Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositis

Shinji Sato, Michito Hirakata, Masataka Kuwana et al. · Arthritis & Rheumatism · 2005 · 742 citations

Life Sciences, Immunology, Pathology +17

Interstitial lung disease in polymyositis and dermatomyositis

I. Marie, É. Hachulla, P. Chérìn et al. · Arthritis Care & Research · 2002 · 486 citations

Medicine, Internal Medicine, Pathology +11

Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?

Richard D. Sontheimer · Journal of the American Academy of Dermatology · 2002 · 483 citations

Medicine, Dermatology, Neurology +9

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

Takahisa Gono, Shoichiro Sato, Yasushi Kawaguchi et al. · Lara D. Veeken · 2012 · 337 citations · Full text

Medicine, Immunology, Internal Medicine +14